Overview

Bold Science. Brighter Medicines. - Our approach addresses a critically underserved link in the biotechnology innovation chain, translating bold ideas for new medicines from preclinical science to clinical proof-of-concept. Many brilliant technologies with potential to generate impactful medicines unnecessarily die on the vine due to lack of the key studies, development plans and visibility required for funding. We believe this problem can be solved by diligent selection, skillful planning and passionate execution.